← FDA DRUG APPROVALS

FDA ANDA · ANDA074619

GLIPIZIDE

Sponsor: BARR LABS INC

APPLICATION
ANDA074619
TYPE
ANDA
ORIGINAL APPROVAL
1997-04-04
LATEST ACTION
2001-08-09
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

GLIPIZIDEDiscontinued
GLIPIZIDE 5MG · TABLET · ORAL
GLIPIZIDEDiscontinued
GLIPIZIDE 10MG · TABLET · ORAL

Approval history

2001-08-09Labeling · Supplement 3AP
2000-07-07Manufacturing (CMC) · Supplement 2AP
2000-05-25Labeling · Supplement 1AP
1997-04-04OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →